Literature DB >> 8236350

Mice expressing a bovine basic fibroblast growth factor transgene in the brain show increased resistance to hypoxemic-ischemic cerebral damage.

V MacMillan1, D Judge, A Wiseman, D Settles, J Swain, J Davis.   

Abstract

BACKGROUND AND
PURPOSE: Cerebral intraventricular infusion of acidic or basic fibroblast growth factor has been shown to attenuate ischemic damage to hippocampal CA1 neurons in the gerbil. The purpose of the present study was to determine if the basic fibroblast growth factor transgenic mouse has an enhanced ability to resist the effects of severe cerebral hypoxemia-oligemia.
METHODS: Mice that were transgenic for bovine basic fibroblast growth factor were exposed to right carotid artery ligation, hyperglycemia, and 20 minutes of 1% carbon monoxide. After 5 days' recovery, brains were examined for histological damage.
RESULTS: Counts of CA1 neurons in the right hippocampus showed a significantly higher number of neurons per millimeter CA1 in hypoxic-ischemic transgenic mice compared with nontransgenic controls (transgenic, 260 +/- 33; nontransgenic, 151 +/- 37 neurons per millimeter CA1; P < .05).
CONCLUSIONS: The results indicate that basic fibroblast growth factor transgenic mice, as judged by CA1 hippocampal neuronal survival, have an enhanced ability to resist the effects of a complex hypoxic-ischemic cerebral insult.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8236350     DOI: 10.1161/01.str.24.11.1735

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  9 in total

1.  Fibroblast growth factor 2 control of vascular tone.

Authors:  M Zhou; R L Sutliff; R J Paul; J N Lorenz; J B Hoying; C C Haudenschild; M Yin; J D Coffin; L Kong; E G Kranias; W Luo; G P Boivin; J J Duffy; S A Pawlowski; T Doetschman
Journal:  Nat Med       Date:  1998-02       Impact factor: 53.440

2.  The fibroblast growth factor receptor-1 is necessary for the induction of neurite outgrowth in PC12 cells by aFGF.

Authors:  H Y Lin; J Xu; D M Ornitz; S Halegoua; M J Hayman
Journal:  J Neurosci       Date:  1996-08-01       Impact factor: 6.167

3.  Blood-brain barrier transport of 125I-labeled basic fibroblast growth factor.

Authors:  Y Deguchi; T Naito; T Yuge; A Furukawa; S Yamada; W M Pardridge; R Kimura
Journal:  Pharm Res       Date:  2000-01       Impact factor: 4.200

4.  A mouse model of cerebral oligemia: relation to brain histopathology, cerebral blood flow, and energy state.

Authors:  Konstanze Plaschke; Clemens Sommer; Helmut Schroeck; Dejana Matejic; Marika Kiessling; Eike Martin; Markus A Weigand; Hubert J Bardenheuer
Journal:  Exp Brain Res       Date:  2004-12-07       Impact factor: 1.972

Review 5.  What animal models have taught us about the treatment of acute stroke and brain protection.

Authors:  S H Ahmed; A Y Shaikh; Z Shaikh; C Y Hsu
Journal:  Curr Atheroscler Rep       Date:  2000-03       Impact factor: 5.113

6.  Fibroblast growth factor-2 induces astroglial and microglial reactivity in vivo.

Authors:  Diane R Goddard; Martin Berry; Sara L Kirvell; Arthur M Butt
Journal:  J Anat       Date:  2002-01       Impact factor: 2.610

7.  Transgenic mice expressing the human heat shock protein 70 have improved post-ischemic myocardial recovery.

Authors:  J C Plumier; B M Ross; R W Currie; C E Angelidis; H Kazlaris; G Kollias; G N Pagoulatos
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

8.  Abnormal bone growth and selective translational regulation in basic fibroblast growth factor (FGF-2) transgenic mice.

Authors:  J D Coffin; R Z Florkiewicz; J Neumann; T Mort-Hopkins; G W Dorn; P Lightfoot; R German; P N Howles; A Kier; B A O'Toole
Journal:  Mol Biol Cell       Date:  1995-12       Impact factor: 4.138

9.  Fibroblast growth factors 1 and 2 in cerebrospinal fluid are associated with HIV disease, methamphetamine use, and neurocognitive functioning.

Authors:  Ajay R Bharti; Steven Paul Woods; Ronald J Ellis; Mariana Cherner; Debra Rosario; Michael Potter; Robert K Heaton; Ian P Everall; Eliezer Masliah; Igor Grant; Scott L Letendre
Journal:  HIV AIDS (Auckl)       Date:  2016-04-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.